Protecting patient access to quality, affordable community-based treatment.
PACT Coalition Joins 15 Organizations Opposed to MedPAC Part B Recommendations
On April 5, 2017, the PACT Coalition joined 15 other organizations in expressing concern over policies MedPAC is considering to reduce Medicare payments for Part B medicines.
The state of community cancer treatment in America.
More than 1,300 community cancer care centers have closed, been consolidated into hospitals, merged or reported financial problems since 2008. 63% of small practices report they are likely to merge, sell or close operations within the next year. Learn More
Why community-based treatment?
Policies are contributing to the continuing shift in care delivery out of the community setting, increasing costs for both patients and Medicare.
A recent study found that chemotherapy costs per dose are 189% higher in the hospital outpatient setting compared to the oncologist’s office, costing patients $134 per dose received on average. This had led to decreased access, reduced adherence, and an increased total cost of care. Annually, Medicare beneficiaries face $650 more in out-of-pocket co-payments for chemotherapy in the hospital setting than in community care settings. This difference costs Medicare approximately $6,500 more per year, per patient.
Hear doctors talking about the benefits of community-based treatment in their respective communities.